What is Protenus?
Founded in 2014 and headquartered in Baltimore, Maryland, Protenus provides a sophisticated platform designed to safeguard patient privacy in electronic health records (EHR). By leveraging advanced data science, machine learning, and behavioral analytics, the company monitors clinical interactions to detect and mitigate unauthorized access to sensitive health information. Protenus serves as a vital infrastructure layer for healthcare organizations, ensuring compliance and operational integrity through proactive, context-aware security measures that address the complexities of modern medical data management.
How much funding has Protenus raised?
Protenus has raised a total of $52.6M across 7 funding rounds:
Other Financing Round
$50K
Debt
$770K
Other Financing Round
$150K
Series A
$2.6M
Series B
$11M
Series C
$17M
Series D
$21M
Other Financing Round (2014): $50K with participation from Dream iT Ventures
Debt (2014): $770K, investors not publicly disclosed
Other Financing Round (2015): $150K supported by Tedco
Series A (2016): $2.6M featuring Tedco, Arthur Ventures, Cognosante, Baltimore Angels, LionBird Venture Capital, and Dreamit Ventures
Series B (2018): $11M backed by Lionbird Venture Capital, F-Prime Capital Partners, Kaiser Permanente Ventures, and Arthur Ventures
Series C (2019): $17M with participation from F-Prime Capital, Lionbird, Kaiser Permanente Ventures, Arthur Ventures, Providence Ventures, and LTP
Series D (2021): $21M led by LionBird, Providence Ventures, MemorialCare Innovation Fund, F-Prime Capital Partners, Gaingels, Kaiser Permanente Ventures, Arthur Ventures, and Transformation Capital
Key Investors in Protenus
F-Prime Capital
Founded in 2002, F-Prime Capital provides a team of investors, engineers, doctors, and scientists dedicated to investing in health care and technology for other companies.
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare, focusing on advancing healthcare innovation and bridging the gap between the healthcare system and the innovation ecosystem.
Arthur Ventures
Arthur Ventures is an early growth capital firm that specializes in leading investments in B2B software companies across the U.S. and Canada, supporting companies in their growth phase.
What's next for Protenus?
With the infusion of capital from its latest financing round, Protenus is well-positioned to accelerate its enterprise-level expansion and deepen its technological moat. The company is expected to focus on scaling its machine learning capabilities to address emerging threats in the healthcare IT sector. By maintaining strong partnerships with strategic investors, Protenus is poised to further integrate its solutions into large-scale healthcare delivery systems, driving long-term value and reinforcing its market dominance in the health-tech security vertical.
See full Protenus company page
